INT183736

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.31
First Reported 2005
Last Reported 2005
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 7
Disease Relevance 0.66
Pain Relevance 0.31

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (Anks1b) nucleus (Anks1b) cellular_component (Anks1b)
biological_process (Anks1b) cytoplasm (Anks1b)
Anks1b (Mus musculus)
Pain Link Frequency Relevance Heat
cytokine 49 86.40 High High
Enkephalin 7 60.72 Quite High
chemokine 7 5.00 Very Low Very Low Very Low
Inflammation 7 5.00 Very Low Very Low Very Low
alcohol 7 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Infection 140 86.08 High High
Sprains And Strains 7 83.28 Quite High
Meningoencephalitis 14 78.56 Quite High
Death 21 67.92 Quite High
Communicable Diseases 14 5.00 Very Low Very Low Very Low
Cancer 14 5.00 Very Low Very Low Very Low
Immunization 7 5.00 Very Low Very Low Very Low
Weight Loss 7 5.00 Very Low Very Low Very Low
Disease 7 5.00 Very Low Very Low Very Low
Viral Infection 7 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Although deprotected CpG ODN 1555 and CpG ODN fma1555 exhibited an identical electrophoretic mobility indicative of an identical DNA sequence, deprotected ODN 1556 displayed a slightly different mobility.
Positive_regulation (deprotected) of CpG ODN 1555
1) Confidence 0.31 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0
The immunostimulatory properties of CpG ODN fma1555 were evaluated in vivo in mice and compared with those of CpG ODN 1555, which were described earlier (43).
Positive_regulation (properties) of fma1555
2) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0.04
RP-HPLC analysis of purified CpG ODN fma1555 was performed using an analytical 5 ?
Positive_regulation (purified) of fma1555
3) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0
As shown in Figure 3, splenocytes from Balb/c mice treated with CpG ODN fma1555 had a delayed increase in IL-6 and IL-12 secreting cells when compared to mice that received CpG ODN 1555.
Positive_regulation (received) of CpG ODN 1555
4) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0 Pain Relevance 0.14
Purified CpG ODN fma1555, CpG ODN 1555 and ODN fma1556 were assayed for endotoxins using the Limulus amebocyte lysate assay and were found to contain <0.1 endotoxin unit per mg of oligonucleotide.


Positive_regulation (Purified) of fma1555
5) Confidence 0.27 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0.08 Pain Relevance 0.06
This study demonstrated that the thermolytic CpG-ODN fma1555 is biologically active and can elicit a protective immune response in mice infected with an intracellular pathogen.
Positive_regulation (active) of fma1555
6) Confidence 0.25 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0.49 Pain Relevance 0
Purified CpG ODN fma1555, CpG ODN 1555 and ODN fma1556 were assayed for endotoxins using the Limulus amebocyte lysate assay and were found to contain <0.1 endotoxin unit per mg of oligonucleotide.


Positive_regulation (Purified) of CpG ODN 1555
7) Confidence 0.14 Published 2005 Journal Nucleic Acids Research Section Body Doc Link PMC1156963 Disease Relevance 0.08 Pain Relevance 0.06

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox